Logo image of CGBD

CARLYLE SECURED LENDING INC (CGBD) Stock Fundamental Analysis

NASDAQ:CGBD - Nasdaq - US8722801029 - Common Stock - Currency: USD

14.18  +0.06 (+0.42%)

After market: 14.18 0 (0%)

Fundamental Rating

5

Overall CGBD gets a fundamental rating of 5 out of 10. We evaluated CGBD against 233 industry peers in the Capital Markets industry. CGBD has only an average score on both its financial health and profitability. CGBD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CGBD was profitable.
CGBD had a positive operating cash flow in the past year.
In the past 5 years CGBD has always been profitable.
In the past 5 years CGBD always reported a positive cash flow from operatings.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a decent Return On Assets value of 4.41%, CGBD is doing good in the industry, outperforming 65.24% of the companies in the same industry.
CGBD's Return On Equity of 9.39% is in line compared to the rest of the industry. CGBD outperforms 56.65% of its industry peers.
CGBD's Return On Invested Capital of 4.43% is in line compared to the rest of the industry. CGBD outperforms 56.65% of its industry peers.
CGBD had an Average Return On Invested Capital over the past 3 years of 4.38%. This is below the industry average of 7.84%.
The 3 year average ROIC (4.38%) for CGBD is below the current ROIC(4.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.41%
ROE 9.39%
ROIC 4.43%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.36%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CGBD (36.54%) is better than 81.55% of its industry peers.
CGBD's Profit Margin has improved in the last couple of years.
CGBD has a better Operating Margin (45.14%) than 78.97% of its industry peers.
In the last couple of years the Operating Margin of CGBD has remained more or less at the same level.
CGBD has a Gross Margin (48.37%) which is in line with its industry peers.
CGBD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 45.14%
PM (TTM) 36.54%
GM 48.37%
OM growth 3Y-3.83%
OM growth 5Y-1.49%
PM growth 3Y-26.4%
PM growth 5Y5.7%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, CGBD has about the same amount of shares outstanding.
Compared to 5 years ago, CGBD has less shares outstanding
Compared to 1 year ago, CGBD has an improved debt to assets ratio.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CGBD has an Altman-Z score of 0.83. This is a bad value and indicates that CGBD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CGBD (0.83) is comparable to the rest of the industry.
CGBD has a debt to FCF ratio of 9.24. This is a negative value and a sign of low solvency as CGBD would need 9.24 years to pay back of all of its debts.
The Debt to FCF ratio of CGBD (9.24) is comparable to the rest of the industry.
CGBD has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.06, CGBD perfoms like the industry average, outperforming 48.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 9.24
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CGBD has a Current Ratio of 2.28. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a better Current ratio (2.28) than 74.25% of its industry peers.
CGBD has a Quick Ratio of 2.28. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a Quick ratio of 2.28. This is in the better half of the industry: CGBD outperforms 74.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.28
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

The earnings per share for CGBD have decreased strongly by -11.74% in the last year.
Measured over the past 5 years, CGBD shows a small growth in Earnings Per Share. The EPS has been growing by 2.24% on average per year.
CGBD shows a decrease in Revenue. In the last year, the revenue decreased by -8.02%.
CGBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)-11.74%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)-8.02%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%-12.67%

3.2 Future

The Earnings Per Share is expected to decrease by -5.59% on average over the next years.
The Revenue is expected to grow by 6.47% on average over the next years.
EPS Next Y-18.35%
EPS Next 2Y-9.11%
EPS Next 3Y-5.59%
EPS Next 5YN/A
Revenue Next Year12.52%
Revenue Next 2Y9.13%
Revenue Next 3Y6.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

CGBD is valuated cheaply with a Price/Earnings ratio of 7.54.
Based on the Price/Earnings ratio, CGBD is valued cheaply inside the industry as 87.98% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. CGBD is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.58, which indicates a very decent valuation of CGBD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGBD indicates a rather cheap valuation: CGBD is cheaper than 84.12% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CGBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.54
Fwd PE 8.58
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CGBD is valued a bit cheaper than 76.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.94
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CGBD has a very decent profitability rating, which may justify a higher PE ratio.
CGBD's earnings are expected to decrease with -5.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.36
EPS Next 2Y-9.11%
EPS Next 3Y-5.59%

5

5. Dividend

5.1 Amount

CGBD has a Yearly Dividend Yield of 11.49%, which is a nice return.
CGBD's Dividend Yield is a higher than the industry average which is at 8.10.
Compared to an average S&P500 Dividend Yield of 2.37, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.49%

5.2 History

The dividend of CGBD has a limited annual growth rate of 1.07%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.07%
Div Incr Years4
Div Non Decr Years4
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

112.94% of the earnings are spent on dividend by CGBD. This is not a sustainable payout ratio.
The Dividend Rate of CGBD has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP112.94%
EPS Next 2Y-9.11%
EPS Next 3Y-5.59%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (7/11/2025, 8:00:00 PM)

After market: 14.18 0 (0%)

14.18

+0.06 (+0.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners26.28%
Inst Owner Change0.62%
Ins Owners0.43%
Ins Owner Change14.05%
Market Cap1.03B
Analysts46
Price Target14.28 (0.71%)
Short Float %0.57%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield 11.49%
Yearly Dividend1.88
Dividend Growth(5Y)1.07%
DP112.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date06-30 2025-06-30 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.11%
Min EPS beat(2)-0.5%
Max EPS beat(2)4.72%
EPS beat(4)2
Avg EPS beat(4)0.65%
Min EPS beat(4)-2.82%
Max EPS beat(4)4.72%
EPS beat(8)5
Avg EPS beat(8)1.41%
EPS beat(12)9
Avg EPS beat(12)6.22%
EPS beat(16)11
Avg EPS beat(16)4.73%
Revenue beat(2)1
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-4.93%
Max Revenue beat(4)2.63%
Revenue beat(8)3
Avg Revenue beat(8)-1.19%
Revenue beat(12)7
Avg Revenue beat(12)1.99%
Revenue beat(16)9
Avg Revenue beat(16)1.58%
PT rev (1m)-12.5%
PT rev (3m)-17.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.41%
Valuation
Industry RankSector Rank
PE 7.54
Fwd PE 8.58
P/S 4.44
P/FCF 9.94
P/OCF 9.94
P/B 1.14
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)1.88
EY13.26%
EPS(NY)1.65
Fwd EY11.65%
FCF(TTM)1.43
FCFY10.06%
OCF(TTM)1.43
OCFY10.06%
SpS3.19
BVpS12.41
TBVpS12.41
PEG (NY)N/A
PEG (5Y)3.36
Profitability
Industry RankSector Rank
ROA 4.41%
ROE 9.39%
ROCE 5.61%
ROIC 4.43%
ROICexc 4.57%
ROICexgc 4.57%
OM 45.14%
PM (TTM) 36.54%
GM 48.37%
FCFM 44.71%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.36%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
ROICexc(3y)4.5%
ROICexc(5y)4.19%
ROICexgc(3y)4.5%
ROICexgc(5y)4.19%
ROCE(3y)5.54%
ROCE(5y)5.14%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y2.42%
ROICexc growth 3Y8.12%
ROICexc growth 5Y2.4%
OM growth 3Y-3.83%
OM growth 5Y-1.49%
PM growth 3Y-26.4%
PM growth 5Y5.7%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 9.24
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.64
Cash Conversion N/A
Profit Quality 122.35%
Current Ratio 2.28
Quick Ratio 2.28
Altman-Z 0.83
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)133.19%
Profit Quality(5y)1416.48%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.74%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.64%
EPS Next Y-18.35%
EPS Next 2Y-9.11%
EPS Next 3Y-5.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.02%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%-12.67%
Revenue Next Year12.52%
Revenue Next 2Y9.13%
Revenue Next 3Y6.47%
Revenue Next 5YN/A
EBIT growth 1Y-4.52%
EBIT growth 3Y6.51%
EBIT growth 5Y-0.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.98%
FCF growth 3Y11.32%
FCF growth 5YN/A
OCF growth 1Y-54.98%
OCF growth 3Y11.32%
OCF growth 5YN/A